Roots Analysis has announced the addition of “Digital Health Market: Focus onDigital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution(Software Solution, Gaming Solution and Combination Solution), Type of Therapy(Curative and Preventive), and Purpose of Solution (Medication Replacement andMedication Augmentation” report to its list of offerings.
According to experts, digital therapeutic solutions areprimarily based on behavior modification and are designed to address a varietyof therapeutic needs across a wide range of disease indications. On the otherhand, several digital solutions have been developed to enable remote doctor-patientconsultations. Such solutions witnessed a surge in adoptions amidst theCOVID-19 pandemic.
To order this 500+ page report, which features 160+ figuresand 200+ tables, please visit this link
Key Market Insights
Nearly 230 digital therapeutic solutions are currentlyavailable / under development
Close to 45% of the aforementioned solutions are standalonesoftware applications targeting more than 60 unique indications.
Over 85% of digital therapeutic solutions are intended toreplace medication
Such solutions are currently available / being developed totreat neurological disorders (27%), mental health problems (24%), and certainmetabolic disorders (24%). Alternatively, some digital health products aredesigned to augment the effect of conventional therapeutics and are currentlybeing considered for treating substance use disorders and few mental healthproblems.
220+ clinical trials, focused on digital therapeutics, havebeen registered since 2004
Around 80,000 patients have beenenrolled in clinical research initiatives aimed to validate the efficacy ofdigital therapeutics, and generate real world evidence concerning theirefficacy and safety. Close to 50% of such trials have been / are beingconducted in the US.
Nearly USD 1.9 billion invested by both private and publicinvestors in this domain
~85% of the total capital raised for digitaltherapeutics-related initiatives was from venture capital investors, featuringover 370 participants.
Partnership activity in this field has grown at a CAGR of~42%, between 2015 and 2019
More than 70% of the reported deals were established after2017, with the maximum activity being reported in 2019. Majority of theinstances captured in the report were focused on pilot product offering (29%)and research and development agreements (21%).
North America and Europe are anticipated to capture over70% of the market share by 2030
The market in Asia-Pacificregions is anticipated to grow at a relatively faster pace (23.2%). In 2030,digital solutions targeting metabolic disorders are likely to represent thelargest market share, in terms of revenues from product sales (26%), followedby those intended for mental health problems (20%) and neurological disorders(19%).
To request a sample copy / brochure of this report, pleasevisit this link
Key Questions Answered
§ Who are the leading players engaged in thedevelopment of digital therapeutic solutions?
§ What are the most popular therapeutic areas addressedby digital health solutions?
§ What are the key factors influencing the priceof digital therapeutics?
§ What is the trend of capital investments in thedigital therapeutics market?
§ Which partnership models are commonly adoptedby stakeholders in this industry?
§ What type of marketing strategies are beingadopted by developers in this domain?
§ How is the COVID-19 pandemic likely to impactthe digital therapeutics market?
§ How is the current and future opportunitylikely to be distributed across key market segments?
§ What are the anticipated future trends relatedto digital therapeutics?
The USD 8.86 billion (by 2030) financial opportunity withinthe digital therapeutics market has been analyzed across the followingsegments:
§ Typeof Solution
§ Standalone Software Application
§ Software Application + Device + Personal Coach
§ Software Application + Device + AI Support
§ Software Application + Device
§ Software Application + AI Support
§ Software Application + Personal Coach
§ Other Types of Solutions
§ Purposeof Solution
§ MedicationReplacement
§ MedicationAugmentation
§ Typeof Therapy
§ Curative
§ Preventive
§ BusinessModel
§ Businessto Consumer (Patients and Caregivers)
§ Businessto Business (Healthcare Providers, Payers, Employers andPharmaceutical Companies)
§ TherapeuticAreas
§ CardiovascularDisorders
§ ChronicPain
§ MentalHealth Problems
§ MetabolicDisorders
§ NeurologicalDisorders
§ RespiratoryDisorders
§ SleepDisorders
§ SubstanceUse Disorders
§ Others
§ KeyGeographical Regions
§ NorthAmerica
§ Europe
§ Asia-Pacific
§ Restof the world
The report features inputs from eminent industrystakeholders, according to whom, digital therapeutic solutions are likely towitness enhanced adoption due to their broader applicability, remote guidanceand other advanced features, thereby, offering lucrative opportunities to theirdevelopers. The report includes detailed transcripts of the discussions heldwith following industry experts:
§ EranOfir (Co-Founder and Chief Executive Officer, Somatix)
§ EdouardGasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
§ StephanieTilenius (Co-Founder and Chief Executive Officer, Vida Health)
§ AdamKaufman (ChiefExecutive Officer, CanaryHealth)
§ VijayRavindran (ChiefExecutive Officer, Floreo)
§ PalakhR Sarogi (Vice President, Marketing, Wellthy Therapeutics),Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics)and Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
§ AmelieJanson (Communication Manager, Voluntis)
§ Anonymous(Founder and Chief Executive Officer, UK based Small-sized Company)
The research coversbrief profiles of key players engaged in the development of digital therapeuticsolutions; other popular industry players featured in the report include:
§ Akili Interactive
§ Beats Medical
§ Big Health
§ Bold Health
§ Click Therapeutics
§ CureApp
§ dreem
§ Ehave
§ Ginger
§ Happify Health
§ inMotion VR
§ Kaia Health
§ Lark Health
§ Mahana Therapeutics
§ MindMaze
§ Noom
§ NOVOSI
§ Omada Health
§ Palo Alto Health Sciences
§ Pear Therapeutics
§ Vida Health
§ Welldoc
§ ZOLL Medical
For additional details, please visit
You may also be interested in the following titles:
1. AR / VR BasedHealthcare Digital Marketing Service Providers Market, 2020-2030
2. AI-Based ClinicalTrial Solution Providers Market, 2020-2030
3. Global HandheldUltrasound Imaging Devices Market, 2020-2030
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
